The Journal of Bone and Joint Surgery (American). 2007;89:841-848.
doi:10.2106/JBJS.F.00655
© 2007 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramage, S. C.
Right arrow Articles by Beckman, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramage, S. C.
Right arrow Articles by Beckman, M. J.
Related Collections
Right arrow Basic Science
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

Expression of RANKL in Osteolytic Membranes: Association with Fibroblastic Cell Markers

Samuel C. Ramage1, Nicole H. Urban, PhD1, William A. Jiranek, MD1, Aparna Maiti, PhD1 and Matthew J. Beckman, PhD1

1 Departments of Biochemistry (S.C.R. and M.J.B.) and Orthopaedics (N.H.U., W.A.J., A.M., and M.J.B.), Orthopaedic Research Laboratory, Virginia Commonwealth University School of Medicine, 1112 East Clay Street, Richmond, VA 23298-0614. E-mail address for M.J. Beckman: mjbeckma{at}hsc.vcu.edu

Investigation performed at the Departments of Biochemistry and Orthopaedics, Virginia Commonwealth University School of Medicine, Richmond, Virginia

Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. Flow Cytometry and Imaging Facility paid or directed in any one year, or agreed to pay or direct, benefits of less than $10,000 to a research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which one or more of the authors, or a member of his or her immediate family, is affiliated or associated.

Background: Aseptic loosening is often mentioned as the primary reason for costly revision of total joint arthroplasties. Receptor activator of nuclear factor-{kappa}B ligand (RANKL) appears to be a major factor in the bone resorption observed in periprosthetic osteolysis. RANKL plays an essential role in the recruitment, differentiation, and survival of the osteoclasts implicated in periprosthetic osteolysis. This study was performed in an effort to identify the cell type in the periprosthetic membrane responsible for expression of RANKL.

Methods: Tissues harvested from osteolytic lesions in nine patients undergoing total joint revision were serially sectioned for immunohistochemical analysis. Intercellular adhesion molecule-1 (ICAM-1) and prolyl 4-hydroxylase (5B5) antibodies were used to detect fibroblasts, and anti-CD-163 (Ber-MAC3) was used to detect macrophages. In addition, antibodies to osteoprotegerin (OPG), RANKL, and receptor activator of nuclear factor-{kappa}B (RANK) were utilized. The binding pattern of these antibodies was then viewed with confocal microscopy with the use of only secondary antibodies as method controls.

Results: Histological analysis was confined to areas of the membrane where cells were detected with use of Hoechst 34580 nuclear stain. In the membrane specimens from all nine patients, diffuse RANKL staining was localized to areas lacking cells and more intense staining was seen in areas containing nucleated cells. There was strong colocalization between RANKL and OPG, and there was weak but specific colocalization between RANKL and both 5B5 and ICAM-1. In contrast, there was complete separation of antibody staining of Ber-MAC3 and RANKL, indicating only generalized overlap of the myeloid markers with the RANKL.

Conclusions: RANKL expression was localized to cells that stained positively for fibroblast markers. The data also indicated that there is an intact RANKL/RANK/OPG system in the periprosthetic membrane that could regulate focalized bone resorption in osteolysis.

Clinical Relevance: Identifying the cell types responsible for RANKL production is critical to the development of a strategy to prevent periprosthetic osteolysis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Am Acad Orthop SurgHome page
R. S. Tuan, F. Y.-I. Lee, Y. T. Konttinen, J. M. Wilkinson, and R. L. Smith
What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?
J. Am. Acad. Ortho. Surg., July 1, 2008; 16(suppl_1): S42 - S48.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
L. V. Gulotta, C. Hidaka, S. A. Maher, M. E. Cunningham, and S. A. Rodeo
What's New in Orthopaedic Research
J. Bone Joint Surg. Am., September 1, 2007; 89(9): 2092 - 2101.
[Full Text] [PDF]